News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,219 Results
Type
Article (5099)
Company Profile (25)
Press Release (227095)
Multimedia
Podcasts (3)
Webinars (4)
Section
Business (82259)
Career Advice (463)
Deals (15056)
Drug Delivery (8)
Drug Development (19093)
Employer Resources (30)
FDA (3683)
Job Trends (3917)
News (120209)
Policy (7516)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (295)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14807)
ALS (38)
Alzheimer's disease (295)
Antibody-drug conjugate (ADC) (42)
Approvals (3782)
Artificial intelligence (84)
Autoimmune disease (29)
Automation (6)
Bankruptcy (97)
Best Places to Work (2874)
Biosimilars (32)
Biotechnology (24)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (104)
Cancer (895)
Cardiovascular disease (62)
Career advice (395)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (167)
Cervical cancer (5)
Clinical research (16712)
Collaboration (361)
Compensation (376)
Complete response letters (8)
COVID-19 (311)
CRISPR (13)
C-suite (345)
Cystic fibrosis (28)
Data (1344)
Denatured (2)
Depression (21)
Diabetes (79)
Diagnostics (2119)
Digital health (11)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (33)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (40)
Earnings (42797)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39172)
Executive appointments (430)
FDA (4422)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (344)
Gene editing (24)
Generative AI (7)
Gene therapy (104)
GLP-1 (145)
Government (424)
Guidances (197)
Healthcare (5051)
HIV (11)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (40)
Immuno-oncology (9)
Indications (18)
Infectious disease (339)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (8)
Intellectual property (33)
Interviews (53)
IPO (7882)
IRA (3)
Job creations (1122)
Job search strategy (361)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (106)
Leadership (5)
Legal (2337)
Liver cancer (21)
Longevity (2)
Lung cancer (97)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (142)
MASH (51)
Medical device (3920)
Medtech (3930)
Mergers & acquisitions (7585)
Metabolic disorders (220)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (542)
NextGen: Class of 2026 (1675)
Non-profit (733)
Now hiring (5)
Obesity (88)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (54)
Patient recruitment (100)
Peanut (6)
People (25245)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (5006)
Phase 2 (7238)
Phase 3 (5791)
Pipeline (2013)
Policy (17)
Postmarket research (625)
Preclinical (1948)
Press Release (66)
Prostate cancer (58)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (182)
Real estate (1886)
Recruiting (8)
Regulatory (5548)
Reports (17)
Research institute (309)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (50)
Series A (53)
Series B (57)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1018)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (82)
Venture capital (10)
Weight loss (30)
Women's health (6)
Date
Today (76)
Last 7 days (188)
Last 30 days (574)
Last 365 days (8973)
2026 (955)
2025 (9043)
2024 (11040)
2023 (13205)
2022 (18666)
2021 (19687)
2020 (18238)
2019 (13206)
2018 (10205)
2017 (10001)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11792)
Australia (1691)
California (3579)
Canada (1149)
China (172)
Colorado (145)
Connecticut (165)
Delaware (71)
Europe (25521)
Florida (548)
Georgia (67)
Idaho (24)
Illinois (164)
India (17)
Indiana (107)
Iowa (9)
Japan (169)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (354)
Massachusetts (2848)
Michigan (104)
Minnesota (203)
Mississippi (1)
Missouri (33)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1030)
New Mexico (5)
New York (822)
North Carolina (483)
North Dakota (4)
Northern California (1880)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (602)
Puerto Rico (2)
Rhode Island (19)
South America (279)
South Carolina (17)
Southern California (1316)
Tennessee (63)
Texas (488)
United States (12472)
Utah (111)
Virginia (85)
Washington D.C. (17)
Washington State (299)
West Virginia (2)
Wisconsin (58)
Wyoming (1)
232,219 Results for "pepgen corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 13, 2025
·
10 min read
Press Releases
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer
December 9, 2025
·
2 min read
Press Releases
PepGen to Participate in Upcoming November 2025 Investor Conferences
November 4, 2025
·
1 min read
Press Releases
PepGen Announces Proposed Public Offering
September 25, 2025
·
3 min read
Press Releases
PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule
November 13, 2025
·
5 min read
Press Releases
PepGen Announces Pricing of $100 Million Public Offering
September 24, 2025
·
3 min read
Press Releases
PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
August 8, 2025
·
9 min read
Press Releases
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer
December 10, 2025
·
2 min read
Press Releases
PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients
September 24, 2025
·
10 min read
Duchenne Muscular Dystrophy
Déjà Vu for PepGen as FDA Places Hold on DMD Drug
The FDA has put a stop to U.S. initiation of PepGen’s Phase II trial for its Duchene muscular dystrophy treatment. The company faced the same hurdle for an earlier neuromuscular candidiate in 2023.
December 16, 2024
·
2 min read
·
Annalee Armstrong
1 of 23,222
Next
